Complications of diabetes: renal disease and promotion of self-management

NHS Centre for Reviews and Dissemination
Record ID 32000008158
Authors' objectives:

This bulletin aims to summarise the available evidence on renal disease and promotion of self-management in diabetes

Authors' recommendations: Over a million people in the United Kingdom have Type 2 (non-insulin dependent) diabetes. The urine of people with Type 2 diabetes should be tested regularly (at least annually) for proteinuria and, if this is negative, for microalbuminuria. Two or more measurements should be carried out. The blood pressure of people with diabetes should be checked at regular intervals and treatment offered if it is found to be consistently higher than 140/90. In people with above-normal levels of protein in their urine, treatment with ACE inhibitors is appropriate, even if blood pressure is within the normal range. Treatment of other cardiovascular risk factors should also be considered. Blood glucose levels should be kept as near to normal as is consistent with an acceptable quality of life. People with Type 2 diabetes should be actively encouraged to be involved in their own care. Further research is necessary to determine whether interventions to promote self-management have positive significant long-term effects on outcomes such as weight and HbA1c levels. All future research should consider clinically relevant outcomes such as morbidity, mortality, and quality of life.
Authors' methods: Review
Project Status: Completed
Year Published: 2000
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England
MeSH Terms
  • Diabetes Mellitus
  • Self Care
Organisation Name: University of York
Contact Address: University of York, York, Y01 5DD, United Kingdom. Tel: +44 1904 321040, Fax: +44 1904 321041,
Contact Name:
Contact Email:
Copyright: Centre for Reviews and Dissemination
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.